Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6

Caroline Vance(The University of Sydney), Boris Rogelj(The University of Sydney), Tibor Hortobágyi(The University of Sydney), Kurt J. De Vos(The University of Sydney), Agnes L. Nishimura(The University of Sydney), Jemeen Sreedharan(The University of Sydney), Xun Hu(The University of Sydney), Bradley Smith(The University of Sydney), Deborah Ruddy(The University of Sydney), Paul D. Wright(The University of Sydney), Jeban Ganesalingam(The University of Sydney), Kelly L. Williams(The University of Sydney), Vineeta Tripathi(The University of Sydney), Safa Al‐Saraj(The University of Sydney), Ammar Al‐Chalabi(The University of Sydney), P. Nigel Leigh(The University of Sydney), Ian P. Blair(The University of Sydney), Garth A. Nicholson(The University of Sydney), Jackie de Belleroche(The University of Sydney), Jean‐Marc Gallo(The University of Sydney), Christopher C.J. Miller(The University of Sydney), Christopher E. Shaw(The University of Sydney)
Science
February 26, 2009
Cited by 2,573Open Access
Full Text

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is familial in 10% of cases. We have identified a missense mutation in the gene encoding fused in sarcoma (FUS) in a British kindred, linked to ALS6. In a survey of 197 familial ALS index cases, we identified two further missense mutations in eight families. Postmortem analysis of three cases with FUS mutations showed FUS-immunoreactive cytoplasmic inclusions and predominantly lower motor neuron degeneration. Cellular expression studies revealed aberrant localization of mutant FUS protein. FUS is involved in the regulation of transcription and RNA splicing and transport, and it has functional homology to another ALS gene, TARDBP, which suggests that a common mechanism may underlie motor neuron degeneration.


Related Papers